![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Archimica S.p.a Lodi It, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Hydralazine hydrochloride, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2015-161 - Rev 01
This Chemical Type CEP, issued on October 29, 2020, remains in force until February 10, 2023, ensuring its reliability within the pharmaceutical industry.
Substance Number 829 associated with this CEP further emphasizes